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The sensory characteristics of food, in particular the flavours of food, play a 
very crucial role in the food industry. It is often what consumers associate most 
from food, and it is therefore crucial for food manufacturers like The Tatua Co-
operative Dairy Company to produce flavour ingredients that are unique and of the 
highest quality.   
The Dairy Flavour Ingredients Business Unit at Tatua produces a range of dairy 
flavour ingredients including Butter, Cream and Milk, and Cheese Flavours. Tatua 
exports most of their flavour products worldwide to various food manufacturers, 
enhancing the flavour of the products that such manufacturers produce. Umami or 
savouriness is one of the five primary tastes. It is one of the most important flavour 
characteristic in dairy flavourings. In particular, umami is most needed in many of 
the different cheese flavourings produced by Tatua. 
This project focuses on optimising the release of glutamate from casein. 
Liberated glutamate with a commercial name HCP337 is used as a flavour 
enhancer, increasing the umami of the dairy flavourings that Tatua makes. 
Alternatively, the addition of monosodium glutamate (MSG) can also increase the 
umami of the flavours that Tatua makes, however this is not possible due to a couple 
of reasons: MSG has a negative reputation in the consumers’ mind, as many believe 
consumption of MSG can cause negative health effects; another reason is that 
addition of MSG would prevent Tatua from labelling their products as “natural”. 
Thus, the glutamate used for Tatua’s flavour ingredients is derived from the 
proteolysis of casein.   
Currently, the problem is that very little free glutamate is present in the HCP337 
product even after a very long proteolysis. Therefore, the purpose of this project is 
to comprehensively examine the biochemistry of glutamate release in order to find 
the optimum proteolysis condition and use this knowledge to optimise the current 
process, increasing glutamate release. 
Three techniques were developed over the initial part of the study to quantify 
glutamate, glutamine, and pyroglutamic acid. A thorough set of samples from the 
HCP337 production process were then characterised. We found that indeed there 
was low glutamate content in the HCP337 product, and there was pyroglutamic acid 
in significant amounts. Stability tests of both glutamate and glutamine showed that 
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glutamate is stable and not affected by the processing conditions. On the other hand, 
glutamine is very unstable and converted into pyroglutamic acid spontaneously 
under the processing conditions.  
With this information, various tests were performed with the focus of 
maximising glutamate yield from casein. These tests included: testing the 
proteolytic capacity of new and different enzymes at differing pH values with the 
hope of finding a better and more suitable enzyme at liberating glutamate from 
casein, the use of different acidifying agents in the HCP337 production process, and 
the screening of glutaminase activity within the new enzymes. The presence of 
glutaminase may further increase the glutamate yield, as glutaminase will convert 
the free glutamine released into glutamate instead of it spontaneously forming 
pyroglutamic acid.  
In summary, this study demonstrated that the current HCP337 production 
process is not designed to optimally release glutamate from casein.  Altering the pH 
and enzyme combinations during hydrolysis did not appear to be effective strategies 
to increase glutamate release from casein. More tests on more enzyme should be 
conducted in the future in order to find enzymes that are most effective at releasing 
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1 Chapter 1 
Literature Review 
  
Founded in 1914, the Tatua Co-operative Dairy Company is the oldest 
independent dairy company in New Zealand. One of the key areas that Tatua 
focuses on is flavour ingredients. The flavour ingredients are made from natural, 
high quality dairy ingredients (Tatua, n.d.-b). The purpose of developing flavour 
ingredients is to enhance the flavour and mouthfeel of food products, and reduce 
the cost in a wide range of food formulations (Tatua, n.d.-b). Today, Tatua exports 
more than 94% of its products to more than 60 countries worldwide each year 
(Tatua, n.d.-a).  
Over the years, Tatua has developed a core range of dairy flavour ingredients 
including butter, Cream and Milk, and Cheese Flavours. One important subdivision 
of the flavour sector is the development of cheese flavour ingredients (Tatua, n.d.-
b). Cheese flavour ingredients enhances processed cheese flavours, reduces 
formulation costs by replacing or reducing cheese usage, and reduces supply chain 
costs associated with sourcing, grading, and storing cheeses (Tatua, n.d.-a).  
An important component of the natural cheese flavours that Tatua produces is 
an ingredient called HCP337. HCP337 is a component of a flavour made from the 
digestion of casein. The digestion of casein ultimately liberates free glutamate 
which is needed to enhance the umami of the cheese flavours.    
In the food industry, glutamate is a popular flavour enhancer used to boost the 
umami/ savoury taste (i.e., the fifth basic taste) of food (Bellisle, 1999). Instead of 
liberating glutamate from casein, Tatua can also achieve the same objective by 
adding MSG (Mono Sodium Glutamate) to their flavourings. The problem is the 
addition of MSG to foods has bad reputations among consumers and many people 
prefer foods that are MSG-free and therefore regarded as “organic” and “natural”.     
The purpose of this project is to comprehensively examine the biochemistry of 
glutamate release from casein (the HCP337 production process), finding the 
optimum proteolysis condition, and using this knowledge to optimise the current 
process and increase glutamate release. 
According to Tatua, the present proteolysis treatment (involving the sequential 
breakdown of casein from a very large protein into smaller peptides and eventually 
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free amino acids) releases a small proportion of glutamate (approximately 20%) 
present in casein. Long proteolysis times are subsequently required to maximise the 
release of glutamate from casein hydrolysate. From the point of view of Tatua, the 
long proteolysis period is very uneconomical.   
According to Tatua, the enzymes currently used are non-specific and thus other 
amino acids that make up casein are also liberated in the break-down process. In 
particular, the amino acid glutamine is also liberated from casein. Glutamine does 
not have umami flavour characteristic, but it can be easily converted to glutamate 
via glutaminase (Dura et al., 2002). However, if glutamine is not immediately 
converted into glutamate, it can form into pyroglutamic acid spontaneously 
(Schilling et al., 2004). It was speculated by Tatua that most of the glutamine 
released from the HCP337 production process is lost to pyroglutamic acid.  
This literature review will identify knowledge gaps around this topic: 
 To identify and explain the importance and functions of glutamate 
in foods and food flavours (Section 1.1). 
 To review existing information on the known structure of casein (the 
raw ingredient used to release glutamate) (Section 1.2).  
 To identify what and how pyroglutamic acid is formed. To identify 
all other relevant reactions surrounding glutamate, glutamine, and 
pyroglutamic acid (Section 1.3). 
 To review existing information on known methodology for 
quantifying glutamate, glutamine, and pyroglutamic acid (Section 1.4). 
 To review existing information on the stability of glutamate, 
glutamine, and pyroglutamic acid (Section 1.5). 
 To review existing information on the enzyme glutaminase (Section 
1.6).  
 
1.1 Glutamate and Umami  
Food ingredients containing lots of free amino acids has been used historically 
in order to enhance the sensory qualities of various foods (Bellisle, 1999). The first 
identification of umami was in the year 1908 by a Japanese scientist called Kikunae 
Ikeda (Ikeda, 1909). Ikeda managed to extract the amino acid glutamate from 
seaweed, and concluded that glutamate is the primary source of umami (Ikeda, 
1909). After discovering glutamate as the source of umami, Ikeda patented the 
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production method of making MSG to a company called Ajinomoto (Ikeda, 1909). 
MSG is a food additive that enhances flavour and increases umami in food products 
(Bellisle, 1999). Today, MSG widely used in cooking and food production due to 
its flavour enhancement ability (Bellisle, 1999).  
The mechanism through which taste stimuli for umami is perceived has been 
well studied (Bellisle, 1999). In particular, the biochemistry associated with the 
umami taste was first described in 1987 (Kurihara, 1987). It starts with the 
adsorption of a chemical stimulus with an umami characteristic (Glutamate) to the 
receptor membranes in the taste buds (Kurihara, 1987). This adsorption induces a 
receptor potential in receptor cells and causes a chemical transmitter to be released 
(Bellisle, 1999). The release of a chemical transmitter then triggers an impulse in 
the nerves that mediates gustatory sensitivity (these nerves may be the chorda 
tympani, and/or the glossopharyngeal) (Bellisle, 1999). Ultimately, this leads to 
successive brain relays conveying the message to the primary and secondary cortex 
where the message and impulses are processed and recognised (Bellisle, 1999).  
Glutamate and glutamine are considered as non-essential amino acids (Bellisle, 
1999). These amino acids can be synthesised endogenously from other amino acids 
and precursors in acceptable quantities (Abdallah et al., 2013).  
Endogenous glutamate (glutamate that are synthesised within the body) has 
been observed to participate in many functions from providing a principal fuel in 
the liver and intestinal mucosa and acting as the substrate for urea formation 
(Christensen, 1990). 
Glutamate can also be synthesised in the brain endogenously (Bellisle, 1999). 
This endogenous brain glutamate is not related to any other glutamate found in the 
body (Roth et al., 1995). In the brain, glutamate is a major excitatory 
neurotransmitter in the mammalian brain (Fonnum, 1984; Stanley et al., 1993). 
Glutamate synthesised in the brain is also an important precursor of the 
neurotransmitter g-aminobutyric acid (GABA) (Fonnum, 1984).  
Glutamate is present naturally in many foods consumed by humans. Within 
those foods, glutamate can either be in the free form or bound form (Giacometti, 





Table 1: Glutamate in various foods, (Bellisle, 1999). 
 Bound glutamate 
(mg/100g) 
Free glutamate  
Salmon 2216 36 
Tomatoes 238 140 
Bovine milk 819 2 
Parmesan cheese 9847 1200 
Beef 2846 33 
  
 The levels of glutamate in various proteins has also been calculated. Below are 
some examples: 
Table 2: percentage (%) by weight of amino acid in food protein. * = essential amino 
acid. (Yildiz, 2010). 
Amino acid Egg 
white 
Tuna Beef Chicken Whey Casein Soy Yeast 
Alanine 6.6 6 6.1 5.5 5.2 2.9 4.2 8.3 
Argnine 5.6 6 6.5 6 2.5 3.7 7.5 6.5 
Aspartic acid 8.9 10.2 9.1 8.9 10.9 6.6 11.5 9.8 
Cystine 2.5 1.1 1.3 1.3 2.2 0.3 1.3 1.4 
Glutamic acid 13.5 14.9 15 15 16.8 21.5 19 13.5 
Glycine 3.6 4.8 6.1 4.9 2.2 2.1 4.1 4.8 
Histidine* 2.2 2.9 3.2 3.1 2 3 2.6 2.6 
Isoleucine* 6 4.6 4.5 5.3 6 5.1 4.8 5 
Leucine* 8.5 8.1 8 7.5 9.5 9 8.1 7.1 
Lysine* 6.2 9.2 8.4 8.5 8.8 3.8 6.2 6.9 
Methionine* 3.6 3 2.6 2.8 1.9 2.7 1.3 1.5 
Phenylalanine* 6 3.9 3.9 4 2.3 5.1 5.2 4.7 
Proline 3.8 3.5 4.8 4.1 6.6 10.7 5.1 4 
Serine 7.3 4 3.9 3.4 5.4 5.6 5.2 5.1 
Threonine* 4.4 4.4 4 4.2 6.9 4.3 3.8 5.8 
Tryptophan* 1.4 1.1 0.7 1.2 2.2 1.3 1.3 1.6 
Tyrosine 2.7 3.4 3.2 3.4 2.7 5.6 3.8 5 
Valine* 7 5.2 5 5 6 6.6 5 6.2 
 
 
The examples presented above demonstrates that glutamate is a very common in 
most pretentious foods. Furthermore, glutamate is the most abundant amino acid in 




1.2 Casein  
Casein is the primary protein found in bovine milk (Farrell et al., 2004). Casein 
can be further divided into four main groups; αs1-, αs2-, β-, and к-caseins. The αs1-
casein family constitutes about 40% of the whole casein fraction from bovine milk 
(Farrell, et al., 2004). It consists of 199 amino acid residues and has a molecular 
weight of 23, 615 (Farrell, et al., 2004). The αs2 –casein family constitutes about 
10% of the whole casein fraction in bovine milk (Farrell, et al., 2004). The 
predominant form of this protein in bovine milk contains a disulphide bond, consists 
of 207 amino acid residues, and has a molecular weight of 25, 226 (Farrell, et al., 
2004). The β-casein family constitutes of about 45% of the whole casein fraction 
from bovine milk (Farrell, et al., 2004). This protein is very complex due to the 
action of milk protease plasmin (Farrell, et al., 2004). The к-casein family 
constitutes of about 5% of the whole casein fraction (Farrell, et al., 2004).  
The amino acid residues that make up casein (Table 3) revealed that glutamate 
and glutamine are found in abundance relative to other amino acids. Furthermore, 
casein is readily available at Tatua and thus makes it a great substrate for the making 





Table 3: Amino acid residues that make up caseins (Farrell, et al., 2004).  










Arginine  Arg   6 6 4 5 
Histidine  His   5 3 5 3 
Lysine  Lys   14 24 11 9 
Aspartic acid  Asp   7 4 4 4 
Glutamic acid Glu   25 24 19 12 







  8 11 5 1 
Threonine  Thr   5 15 9 15 
Asparagine Asn   8 14 5 8 
Glutamine  Gln   14 16 20 14 
Cysteine Cys   0 2 0 2 
Glycine  Gly   9 2 5 2 
Proline  Pro   17 19 35 20 
Alanine  Ala   9 8 5 14 
Isoleucine  Ile   11 11 10 12 
Leucine  Leu   17 13 22 8 
Methionine  Met   5 4 6 2 
Phenylalanine  Phe   8 6 9 4 
Tryptophan  Trp   2 2 4 4 
Tyrosine  Tyr   10 12 4 9 
Valine  Val   11 14 19 11 
Total amino 
acids 
    199 207 209 169 
 
1.2.1 Cheese and free amino acids  
In cheese making, flavour development occurs during the ripening process 
(Smit et al., 2000). The ripening process is defined by the breakdown of caseins 
through proteolysis and peptidolysis (Smit, et al., 2000). During proteolysis, caseins 
are broken down into many large peptides (soluble-nitrogen fraction) that are 
responsible for the bitterness flavour in cheese (Smit, et al., 2000). These large 
peptides are then further broken down into smaller peptides and eventually free 
amino acids that contribute to the basic cheese flavour (Smit, et al., 2000). These 
reactions are mediated by proteases and peptidases that may originate from starter 




It has been observed that cheese that contains a high amount of free amino acids 
has the strongest cheese taste (Molina et al., 1999). The main amino acids were 
glutamate, valine, leucine, glutamine, asparagine, aspartate, threonine, and 
isoleucine (Molina, et al., 1999). The majority of free amino acids have sensory 
properties, but glutamate is the only ones that could give a umami taste (Schiffman 
& Engelhard, 1976).  
This observation was supported by several other studies; for example, in 1995, 
a water-soluble extract of comté cheese containing high levels of glutamate and 
small amount of aspartic acid was described as umami (Salles et al., 1995), and 
similarly just recently in 2013, Mayer and Fiechter found that glutamate make up 
most of the total free amino acid of seven commercially produced long ripening 
Italian extra hard parmesan (Fiechter et al., 2013). These findings confirmed the 
influence of free glutamate towards the umami/ savoury flavour.  
 
1.3 Pyroglutamic acid/ pyroglutamate  
Pyroglutamic acid, also known as 5-oxo-L-proline pyrolidone 2-carboxylic 
acid, is an amino acid derivative where the amino group of glutamine or glutamate 
cyclises to form a lactam ring (cyclic amide) (Kumar & Bachhawat, 2012). 
Pyroglutamic acid has also been known based on its structure to be an internally 
cyclized glutamate (Abraham & Podell, 1981).  
Pyroglutamic acid can be formed in a number of ways. In living cells, it can be 
derived from the degradation of glutathione (Kumar & Bachhawat, 2012). 
Pyroglutamic acid can also be formed from the degradation of proteins containing 
pyroglutamic acid at the N-terminus (Figure 1) (Kumar & Bachhawat, 2012). 
Cleavage of N-terminus pyroglutamic acid is done by the enzyme pyroglutamyl 
peptidase (Cummins & O'Connor, 1998). Many peptides and proteins have been 
found to have pyroglutamic acid at the N-terminus (Kumar & Bachhawat, 2012). 
N-terminus pyroglutamic acid is known to play a role in stability and activity of the 
protein (Abraham & Podell, 1981). In the cell, N-terminus pyroglutamic acid is 
made post-translationally by the enzyme glutaminyl cyclase (converting glutamate 
and/ or glutamine into pyroglutamic acid) (Schilling, et al., 2004).   
Glutamine cyclase, catalyses the production of pyroglutamic acid from bound 
glutamine and/or glutamate (Kumar & Bachhawat, 2012). In the absence of 




and/or glutamate but at a much slower rate (Kumar & Bachhawat, 2012). This 
reaction is spontaneous and only occur in proteins that have glutamine or glutamate 
as the N-terminus residue (Schilling, et al., 2004). 
Alternatively, free glutamate can also be transformed into pyroglutamic acid 
non-spontaneously via several key enzymes (γ-glutamyl cysteine synthase, 
glutamine synthase, and glutamate-5-kinase) and energy (ATP) to form the γ-
glutamyl phosphate intermediate (Orlowski & Meister, 1971; Seddon et al., 1989; 
Krishnaswamy et al., 1998; Kumar & Bachhawat, 2012). γ-glutamyl phosphate 
intermediate can then be spontaneously converted into pyroglutamic acid (Figure 
1) (Cummins & O'Connor, 1998).  
 
Figure 1: Different possible pathways for the generation of pyroglutamic acid (Kumar 
& Bachhawat, 2012). 
 
Pyroglutamic acid is very stable and resistant to degradation by amino 
peptidases (Fietzek et al., 1974; Kumar & Bachhawat, 2012). Despite its stability, 
there is one known enzyme called 5-oxoprolinase that can hydrolyse pyroglutamic 
acid into glutamate (Figure 1) (Kumar & Bachhawat, 2012).  5-oxoprolinase is the 
only known enzyme to act on pyroglutamic acid, and is an ATP-dependant enzyme 
containing an ‘actin-like ATPase fold’ (Kumar & Bachhawat, 2010, 2012). Boiling 
pyroglutamic acid under reflux (heating pyroglutamic acid solution with an 
attached condenser to prevent the it from escaping) for 60 minutes at pH 2.5 and 
below, or pH 11 and higher can also revert pyroglutamic acid back to glutamate 




In terms of casein, previous studies have shown that κ-casein found in milk 
contains N-terminal pyroglutamic acid residues (Alais, 1984). Another milk protein 
of the ribonuclease superfamily called angiogenine 2 also contains N-terminal 
pyroglutamic acid residues (Strydom et al., 1997).  
 
1.4 Quantification of glutamate, glutamine, and 
pyroglutamic acid 
In order to comprehensively examine the biochemistry of glutamate release 
from casein three techniques involving the quantification of the three main amino 
acids would have to be developed.  
1.4.1 Quantification of glutamate  
For the quantification of glutamate, several methods can be utilised: 
1. High Performance Liquid Chromatography (HPLC) 
Glutamate has to first be derivatised (transformed into a product with a similar 
chemical structure) with OPA-ME (o-phthalaldehyde - 2-mercaptoethanol) 
solution in order for it to be detectable (Shih, 1985). Acetonitrile-0.04 M sodium 
acetate buffer at pH 5.4 was found to be the best buffer to use as the mobile 
phase (Shih, 1985). It was found that pH 5.4 was the best as it minimises 
interference between glutamate and aspartic acid derivatives (Shih, 1985). 
Lowering the pH of the buffers causes interference to occur (Figure 2) (Shih, 
1985). Derivatised glutamate are then detected using a UV detector at 200nm 
(Shih, 1985).  
  
Figure 2: Elution profile of amino acid standards derivatised by OPA-ME. A) Shows 





2. Enzymatic assay  
 
    L-glutamate + NAD+      ⇌                    α-Ketoglutarate + NH4+ + NADH 
 
 
The quantification of glutamate through enzymatic assay requires glutamic 
dehydrogenase (L-GLDH) (E.C 1.4.1.3) which is used to convert glutamate into 
α-Ketoglutarate (Figure 3) (Lund, 1986). NAD+ is simultaneously reduced to 
NADH, and the level of NADH at the end of the reaction is used to determine 
the level of glutamate as the stoichiometry between glutamate and NADH is 1 
to 1 (Lund, 1986). NADH is quantified by measuring the absorbance value at 
340 nm (Lund, 1986).  
A glutamate standard curve will have to be made by measuring known 
concentrations of glutamate in order to translate absorbance values into 
concentration values (Lund, 1986). 
1.4.2 Quantification of glutamine  
For the quantification of glutamine, several methods can be utilised: 
1. High Performance Liquid Chromatography (HPLC) 
The quantification of glutamine by HPLC is the same as the procedure described 
in Section 1.4.1 for the quantification of glutamate by HPLC.  
 
2. Enzymatic assay  
 
 




             L-glutamate + NAD+            ⇌            α-Ketoglutarate + NH4+ + NADH 
 
  
Glutamic dehydrogenase (L-GLDH) 
Glutaminase  
H+  
Glutamic dehydrogenase (L-GLDH) 
Reaction A 
Reaction B 
Figure 3: Dehydrogenation of glutamate and reduction of NAD+. 





Quantification of glutamine through enzymatic assay requires two steps 
(Figure 4). Endogenous glutamate (glutamate already present in a sample and is 
not glutamate formed by the conversion of glutamine to glutamate via 
glutaminase) concentration must first be determined using the procedures 
described in Section 1.4.1 (Glutamate assay). Once the concentration of 
endogenous glutamate has been determined, glutamine must be deamidated into 
glutamate by glutaminase, Figure 4 (i.e., Reaction A). Glutamate quantification 
is once again done and the values generated now will reflect the glutamate 
concentrations of endogenous origin and of glutamine origin (Lund, 1986).  
Similarly, a glutamine standard curve will have to be made by measuring 
known concentrations of glutamine in order to translate absorbance values into 
concentration values (Lund, 1986).     
 
1.4.3 Quantification of pyroglutamic acid  
For the quantification of pyroglutamic acid, several methods can be utilised:  
1. High Performance Liquid Chromatography (HPLC) 
Several HPLC methods has been described in the literature in order to 
quantify L-pyroglutamic acid.  
 Pyroglutamic acid from the casein hydrolysate can be quantified using 
reversed-phase high performance liquid chromatography with 0.1% 
phosphoric acid as the mobile phase. Pyroglutamic acid is detected using 
a UV detector at 200nm (Figure 5) (Shih, 1985).  
 
Figure 5: Elution profile of underivatised enzymatic casein hydrolysate from a 
commercial source. Mobile phase was 0.1% phosphoric acid (PGL= Pyroglutamic 




 Gandini et al. described an easy and reliable method of determining 
pyroglutamic acid using HPLC. The method described was done using a 
10µl loop, C18 precolumn, and an ODS Hypersil column (Gandini et al., 
1993). The method involves an isocratic elution at 1 ml/min with 7mM 
phosphate buffer, Na2HPO4 (pH 3.5) as the mobile phase (Gandini, et al., 
1993). The downside for this method is the interference of methionine 
peak with pyroglutamic acid peak (Gandini, et al., 1993). The study 
showed that in order to minimise any interference from methionine 
peaks, samples should be treated with 35m/v H2O2 for one hour at room 
temperature (Gandini, et al., 1993). This method allowed for a clear 
pyroglutamic acid peak to be formed with the retention time of 2.93 
minutes (Gandini, et al., 1993).  
 
2. Enzymatic assay: 
 Simultaneous assay method for L-glutamate and L-pyroglutamic acid 
using 5-oxoprolinase (without ATP hydrolysing activity). This method 
was first described by Nishimura et al. in 2001 (Nishimura et al., 2001).  
The method is composed of two steps. First, L-glutamate is measured 
(Reactions A and B, Figure 6). Reactions A and B are done 
simultaneously in a single reaction vessel. The conversion of L-glutamate 
via L-glutamate peroxidase produces H2O2, which is then used in 
Reaction B (Nishimura, et al., 2001). H2O2 then reacts with N-ethyl-N-
(2-hydroxy-3-sulfopropyl)-3, 5-dimethoxyaniline (DAOS), and 4-
aminoantipyrine (4-AA) (Nishimura, et al., 2001). Ultimately a blue 
pigment is then developed and its absorbance can be measured at 600 nm 
(Nishimura, et al., 2001). This first set of reactions simply determines the 
amount of L-glutamate. Once this value has been determined, 5-
oxoprolinase (without ATP hydrolysing activity) can then be added to 
the reaction mixture. 5-oxoprolinase converts L-pyroglutamic acid into 
L-glutamate (Nishimura, et al., 2001). The resulting L-glutamate is 
measured again by the same process as described above. The difference 
in absorbance is used to calculate the amount of L-pyroglutamic acid 
originally present (Nishimura, et al., 2001). Alternatively, L-




glutamate via 5-oxoprolinase and then applying the glutamate assay to 




                  L-glutamate + H2O + O2                      α-Ketoglutarate + NH3 + H2O2 
 
                  H2O2 + DAOS + 4-AA   Blue pigment (600 nm) 
 





L-pyroglutamic acid + H2O    L-glutamate 
 
 




Despite the different pathways L-pyroglutamic acid can be determined, both 
methods relies on the use of 5-oxoprolinase (without ATP hydrolysing activity).  
 
1.4.4 Methods Chosen 
The ability to reliably quantify glutamate, glutamine, and pyroglutamate are the 
‘keys’ to carrying out this study.  
Even though the techniques on quantifying glutamate, glutamine, and 
pyroglutamic acid described in the previous sections are well established, it does 




Reaction A         





Figure 6: Simultaneous assay for L-pyroglutamate quantification. 




of this study. After a lot of discussions, it was decided that the best and most realistic 
approach for quantifying glutamate and glutamine were through enzymatic assay. 
Ideally, the quantification of pyroglutamic acid would be done using an 
enzymatic assay. This would keep the methods consistent and simple. However, 5-
oxoprolinase (without ATP hydrolysing activity), which was discovered in 1999 in 
a cell extract of Alcaligenes faecalis (Nishimura et al., 1999) is needed to convert 
pyroglutamic acid into glutamate. Today, it is near impossible to attain this 
particular enzyme. After a lot of searching and attempts to obtain this enzyme, it 
was found that this enzyme is very rare and very expensive when it is available. 
From this reason only, it was then decided that quantifying pyroglutamic acid 
through enzymatic assay was not a viable option. Quantification of pyroglutamic 
acid through HPLC was then chosen as the more realistic option.  
 
1.5 Glutamate, glutamine, and pyroglutamic acid stability  
The stability of glutamate, glutamine, and pyroglutamic acid is particularly 
important in this study as this will give a better understanding on how these amino 
acids behave in the HCP337 production process.  
A study by Arii et al. looked at the stability of glutamine. Arii et al. used HPLC 
in order to quantify glutamine (Arii et al., 1999). Citrate buffer was used to 
accommodate pH range from 1.21 to 6.41, and borate buffer was used to 
accommodate pH range from 7.39-11.01 (Arii, et al., 1999).  
This study found that degradation of glutamine in an aqueous solution follows 
a first-order reaction kinetics (Arii, et al., 1999). This was determined by the linear 
relationship between the incubation time and the log of percentage of remaining 





Figure 8: Apparent first-order plots for the degradation of Gln at 70˚C in buffer 
solution. pH values: (■) 1.21, (●) 1.93, (▲) 2.87, (▼) 3.93, (♦) 4.80, (  ) 5.61, (◊) 6.41, 
(  ) 7.39, (□) 8.31, (○) 9.31, (○ dot) 11.01 (Arii, et al., 1999). 
 
Figure 8 shows that the stability of glutamine decreases at the extreme ends of 
the pH scale. The rate of degradation for glutamine is a lot slower at near neutral 
pH values (pH 5.61 – 6.41). Degradation of glutamine was found to be due to the 
intramolecular cyclization of glutamine to pyroglutamic acid instead of the 
hydrolytic deamination of glutamine (Arii, et al., 1999).  This observation was 
made by analysing the reaction mixtures using HPLC and the results showed a close 
agreement between the loss of glutamine and the formation of pyroglutamic acid 
(Arii, et al., 1999). Overall, this study found that glutamine is most stable at the pH 
range from 5 to 7.5 (Arii, et al., 1999). 
On the other hand, in 1985, a paper by Gayte-Sorbier et al, looked at the stability 
of glutamate. The aim of this study was to identify and study the different factors 
that can influence the conversion of glutamate under storage and processing, and 
also to identify the conversion product of glutamate (Gayte-Sorbier et al., 1985). 
This study focused on four main factors: pH, oxygen exposure, temperature, and 
storage time in relation to the stability of glutamate (Gayte-Sorbier, et al., 1985).  
The study found that at room temperature, glutamate solutions were very stable 
at the extreme ends of the pH scale (pH 0 and 14) (Gayte-Sorbier, et al., 1985). 




6) (Gayte-Sorbier, et al., 1985). Furthermore, glutamate was more stable in the 
absence of oxygen (Gayte-Sorbier, et al., 1985).  
This study also looked at the effects of boiling and autoclaving (135˚C) to 
glutamate under all pH values. When boiled, glutamate were very stable (over 60 
minutes) in a very acidic, almost neutral and very alkaline pH (Gayte-Sorbier, et 
al., 1985). This study also found two lability maxima (pH 11, and pH 2) when 
glutamate is boiled (Gayte-Sorbier, et al., 1985). On the other hand, when 
autoclaved, glutamate showed greatest stability in the extreme ends of the pH scale, 
and poorest stability at pH 2 to 3.5 (Gayte-Sorbier, et al., 1985). Although not as 
much as between pH 2 to 3.5, glutamate also showed a degree of instability between 
pH 8 to 13. As expected, the rate of conversion is much faster at the autoclaving 
temperature than that of the boiling temperature. In both cases glutamate converted 
to pyroglutamic acid only (Gayte-Sorbier, et al., 1985).   
Additionally, the stability of glutamine, glutamate, and pyroglutamic acid was 
also covered in another paper. Stability was determined by dissolving these amino 
acids in solutions of different pH, and at different temperatures (Shih, 1985). The 
levels of the amino acids were then analysed at regular intervals using the methods 
described above (Section 1.4) (Shih, 1985). The results were: 
 Pyroglutamic acid: very stable and under extreme conditions (2M 
hydrochloric acid, at 100˚C for 2h), it can be converted into glutamate 
spontaneously (Shih, 1985).  
 Glutamate: Stable at room temperatures, but has the tendency to 
form pyroglutamic acid at higher temperatures and extended storage time 
(Shih, 1985).  
 Glutamine: Extremely unstable, and is readily deamidated at 
alkaline pH values, long storage time, and elevated temperature (Shih, 
1985). Most of the reaction product was pyroglutamic acid, rather than 





Figure 9: Effect of pH on glutamine (o) and pyroglutamic acid (∆) at 37˚C for 24 h in 
0.1M sodium phosphate buffer adjusted to the according pH by phosphoric acid or 
sodium hydroxide (Shih, 1985). 
 
A typical condition for enzyme hydrolysis is at 37˚C for 24 h (Shih, 1985). 
Figure 9 shows the effect of pH on glutamine when exposed to the normal 
conditions for enzyme hydrolysis. Very clearly, as pH rises, glutamine loss 
increases, and the formation of pyroglutamic acid increases (Shih, 1985). This 
observation is contradictory to the ones made in the previous study (Figure 8) where 
glutamine was found to be most stable at just under neutral pH and most unstable 
in low pH. The differing results from the two papers may be due to the temperatures 
that the test were carried out at. The test in Figure 8 was done at 70˚C, whereas, the 
test in Figure 9 was done at 37˚C.  
 
1.6 Glutaminase  
Glutaminase (EC 3.5.1.2) is an amidohydrolase enzyme that deamidate L-
glutamine in the presence of water and produces L-glutamate and ammonia 
(McCauley et al., 1999). Depending on the origin of the enzyme, it may have 
different characteristics. For example, L-glutaminase from Streptomyces 
avermitilis is active at pH 3-11, exhibits optimum activity at pH 7-8, and has an 
optimal temperature of 30˚ C (Abdallah, et al., 2013). L-glutaminase from 




8.5, and has an optimal temperature of 40˚ C (Dura, et al., 2002). L-glutaminase 
from C. albidus that has an optimum activity at temperatures of 70˚ C (Dura, et al., 
2002).  
There is a very close analogue of EC 3.5.1.2 called protein glutaminase (PG) 
(EC 3.5.1.44) that deamidates glutamine residues in protein, to form glutamate 
residues (Hashizume et al., 2011). In contrast to glutaminase, protein glutaminase 
cannot deamidate free glutamine (Hashizume, et al., 2011; KEGG, n.d.).  
The use of glutaminase in the HCP337 production process can further increase 
the glutamate yield from the HCP337 production process. Unfortunately, at the time 
of this study, the use of pure glutaminase in the production of flavours at Tatua was 







2 Chapter 2 
Methodology 
This chapter is dedicated for the refinement, optimisation, and validation of the 
methodology that were chosen in Section 1.4.4.   
2.1 Glutamate assay 
As a starting point, the method described in the Sigma Product information for 
Glutamine/ Glutamate determination kit (GLN1) which was derived from Lund, 
1986 (Section 1.4.1) was used as a general outline in the development and 
validation of an optimised glutamate assay for this study.  
Briefly, the quantification of glutamate was done through the reduction of 
NAD+ to NADH, and the amino group of glutamate oxidised to α-Ketoglutarate. 
The whole reaction is mediated by the enzyme glutamic dehydrogenase (L-GLDH) 
(EC 1.4.1.2) (Figure 10).  
 
    L-glutamate + NAD+              ⇌                α-Ketoglutarate + NH4+ + NADH 
 
 
The quantification of glutamate was done by measuring the change in 
absorbance value of the mixture by putting it in a spectrophotometer at a 
wavelength of 340nm at room temperature. The spectrophotometer used for this set 
up was a Biochrom Libra S60 Double Beam Spectrophotometer.  
 
2.1.1 Buffers  
The buffer suggested in the sigma Product information for Glutamine/ 
Glutamate determination kit was Tris (0.1M)-EDTA (0.002M) buffer (TE buffer) 
adjusted to pH 9. Before testing TE buffer, phosphate buffer was first trialled at pH 
7, 7.5, and 8. This was done as phosphate buffer was an acceptable buffer for food 
processing.   
Glutamic dehydrogenase (L-GLDH) 




NAD+ (C-NAD-25G, from Megazyme, Wicklow, Ireland) was tested at 10mM. 
ADP (216J0000 from Calzyme Laboratories San Luis Obispo, CA, USA)  which is 
an activator of the enzyme glutamic dehydrogenase was tested at 1mM (Prough et 
al., 1973). Glutamic dehydrogenase (GLDH, 080A0010 from Calzyme 
Laboratories, San Luis Obispo, CA, USA) was reconstituted to 5mg/mL with 
phosphate buffer at pH 7, and glutamate (the substrate, purchased from Sigma-
Aldrich with the product code G1251) was tested at 1mM. A summary of the 
components for the tests are shown below:  
Table 4: Components for glutamate assays. Phosphate buffer tests. 
Phosphate buffer test 1 
1mM Glutamate  
10mM NAD+ 
1mM ADP 
5mg/mL GLDH  
Phosphate buffer (pH 7, 7.5, and 8) 
Reaction volume: 1.025mL 
 
 
























Figure 12: TE buffer pH test results, absorbance vs. time, 0.4mM glutamate.  
 
The conclusion of these tests revealed that the higher the pH of phosphate 
buffer, the faster the reaction reached equilibrium (evident by the plateau). On top 
of this the results showed a lot of inconsistencies evident by the differing values of 
final absorbance even though all of the tests used a consistent concentration of 
glutamate of 1mM (Figure 11).  It is speculated that the inconsistencies in the final 
absorbance values may be due to the glutamic dehydrogenase operating at 
unfavourable pH.  
For the TE buffer, three pH values (pH 8.5, 9, and 9.5) were made and tested. 
Initially, a concentration of 1mM of glutamate was used for the test. 1mM NADH 
(derived from glutamate, 1 to 1 stoichiometry) however was found to be too high 
for the detection limit of the spectrophotometer. The graph obtained from this test 
(data not shown) showed minimal increase in absorbance, as the starting absorbance 
values were already too high. For this reason, a much lower concentration of 
glutamate of 0.4mM was then found to be much suitable for the detection limits of 
the spectrophotometer. Other reagents needed to complete the reaction were kept 
constant to the previous test.  
The results for the TE buffer pH test concur with the previous phosphate buffer 
pH tests. The higher the pH of the buffer, the faster the reaction reaches equilibrium 
evident by the plateauing of the slope (Figure 12). In this case, TE buffer at pH 8.5 






















This is evident by the lower final absorbance value compared to the other two pH 
values (Figure 12). Nevertheless, this test signifies the importance of buffer pH and 
its ability to hinder a complete reaction if the pH is sub-optimal for the enzyme 
mediating the reaction. Compared to the phosphate buffer, TE buffer reached 
equilibrium faster. Reactions in phosphate buffer reached equilibrium (evident by 
the plateauing of the slope) around 40 to 60 minutes depending on the pH of the 
buffer (Figure 11). In contrast, reactions in TE buffer reached equilibrium around 
10 to 15 minutes depending on the pH of the buffer (Figure 12). From these results 
it was then concluded that TE buffer at pH 9.5 will be used for the glutamate assay.  
Theoretically, the concentration of NADH can be calculated using the formula: 
 Δ𝐴 = 𝜀𝐶𝑙 
Where ∆A is the change in absorbance, 𝜀 is the extinction coefficient of NADH at 
340nm, C is concentration of NADH, and l is the path length. The extinction 
coefficient of NADH is 6220 M-1cm-1, and the path length is 1cm. Using 0.4mM as 
the concentration, the change in absorbance should be about 2.48. Since the 
reagents for the glutamate assay already have a baseline absorbance value of about 
0.6, the final absorbance value should be around 3.08. However, this theoretical 
value does not correspond to the experimental results generated. For example, in 
(Figure 12) 0.4mM of glutamate resulted in a plateauing just under the absorbance 
value of 2. This disagreement is due to the reversible nature of the reaction (Figure 
10). For this reason, the quantification of glutamate will have to be done using a 
standard curve.   
 
2.1.2 NAD+ Optimization  
The next step was to find if the glutamate in the reaction presented in Figure 13 
is fully converted. Incomplete glutamate conversion could occur if not enough 
NAD+ is used in the assay. It is important to remember that the reaction in Figure 
13 is reversible, and if the driving force for the forward direction is weak, then the 
reverse reaction is favoured transforming α-Ketoglutarate back into L-glutamate. 
 
   L-glutamate + NAD+      ⇌             α-Ketoglutarate + NH4+ + NADH 
 
 
Glutamic dehydrogenase (L-GLDH) 




The reverse reaction in all cases should be prevented as it will diminish the accuracy 
of the results. Thus, in order to reduce the undesired reverse reaction, NAD+ should 
be at a high enough concentration so that the forward reaction is always favoured.  
To test this, three NAD+ concentrations (12, 14, and 15mM) were tested along 
with 0.3mM of glutamate as the substrate, 1mM of ADP, 5mg/ml GLDH, and TE 
buffer, pH 9.5. The results are presented in Figure 14. 
 
Figure 14: NAD+ optimization results. Absorbance vs. time. 
 
By increasing the NAD+ concentration, it was clear that the forward reaction is 
more favourable, evident from the final absorbance values of the reactions (Figure 
14). In this case 12mM of NAD+ was still not enough to allow full conversion of 
the glutamate into α-ketoglutarate evident by the lower final absorbance value 
compared to the other two NAD+ concentrations (Figure 14). On the other hand, 
both 14 and 15mM showed a very similar final absorbance values, suggesting that 
these concentrations of NAD+ were sufficient enough to drive the forward reaction 

























2.1.3 ADP Optimization  
As stated before, ADP is needed for this reaction as it is an activator for glutamic 
dehydrogenase. To investigate the importance of ADP, an identical assay to the one 
performed for the NAD+ test was done using no ADP and the results showed no 
change in absorbance value. ADP is thus a crucial component of the glutamate 
assay. How much ADP is required for this reaction to operate optimally? The 
previous tests used 1mM of ADP as a starting point, however this may be too much 
and thus wasteful.  
To test this, two ADP concentrations below 1mM were tested (0.5mM and 
0.7mM) along with 0.3mM of glutamate, 15mM NAD+, 5mg/ml GLDH, and TE 
buffer, pH 9.5. The results are presented in Figure 15.  
 
Figure 15: ADP optimization result. Absorbance vs. time. 
 
From the results above, using both 0.5 and 0.7mM of ADP has no 
indistinguishable differences on the rates and the final absorbance value (Figure 
15). Therefore the assays were done using the lower ADP concentration of 0.5mM, 



























2.1.4 Glutamic dehydrogenase (L-GLDH) optimization  
The last component to optimise for the glutamate assay was the enzyme 
glutamic dehydrogenase. All previous tests have used this enzyme at a 
concentration of 5mg/mL at 20µl. 
To start, three volumes (5, 10, and 25µl) of glutamic dehydrogenase at 5mg/mL 
were tested with 0.3mM glutamate, 15mM NAD+, 0.5mM ADP, and TE buffer, pH 






Figure 16: A) Glutamic dehydrogenase (L-GLDH) optimization, test 1 results. 
Absorbance vs. time. B) Debunking the irregular trends observed from the previous 













































7.5µl GLDH showing 
proper rates due to even 
mixing from the beginning.  
 
The point where the samples 
are further mixed using a 





At first glance, Figure 16A looks unusual as the rate for the reaction with only 
5µl of L-GLDH is faster than the reaction with 10µl of L-GLDH. However it was 
then found that the culprit behind this phenomena is improper mixing of reagents 
before the reaction started (Figure 16B).  
To conclude, the rate of reaction is proportional to the volume of L-GLDH as 
expected. 25µl of L-GLDH at 5mg/mL gave the fastest rate of reaction and was 
thus chosen as the final amount and concentration for the glutamate assay.  
 
2.1.5 Optimised glutamate assay  
The final set of conditions are selected based on the results of the tests presented 
above. 
 
Table 5: Final set of conditions for glutamate assay. The values described below are 
representative for one assay.  
Sample containing Glutamate  100µl (Glutamate concentration ≤ 0.4mM) 
NAD+ 150µl (final concentration of 15mM) 
ADP 5µl (final concentration of 0.5mM) 
L-GLDH 25µl at 5mg/mL 
Buffer  745µl TE buffer, pH 9.5 
Reaction volume  1.025mL 
Detection wavelength  340nm 
 
2.1.6 Glutamate assay standard curve  
Using the conditions set out for the glutamate assay, a standard curve was 
generated in order to determine samples with unknown concentration of glutamate. 
Four glutamate concentrations ranging from 0.1mM to 0.4mM were made and 






Figure 17: Glutamate assay standard curve along with equation. 
The formula used to calculate the concentration of glutamate from absorbance is: 
𝒚 = −𝟓. 𝟏𝟓𝟔𝟐𝒙𝟐 + 𝟓. 𝟕𝟗𝟗𝟒𝒙 − 𝟎. 𝟎𝟐𝟖𝟕 
 
2.2 Glutamine assay  
The glutamine assay is a coupled reaction with the glutamate assay. The first 
step of the glutamine assay is the conversion of glutamine to glutamate via 
glutaminase (EC 3.5.1.2) (Figure 18).  
 
 





Glutamate is then quantified through the already established glutamate assay. If 
the samples tested contains both glutamate and glutamine, to properly quantify 
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Glutaminase  




glutamate should be determined separately, and the concentration of glutamine 
calculated from their difference. 
Once again, the method from Sigma (GLN1) was used as a baseline to start the 
development of the glutamine assay.  
The Sigma approach to the glutamine assay requires 0.2mL of 0.5M of acetate 
buffer at pH 5, 0.45mL of deionised water, 0.25mL of glutamine containing sample, 
and 0.1mL of glutaminase diluted first in 10% of the 0.5M acetate buffer. All of 
these equates to a reaction volume of 1mL and 1 unit of glutaminase is used. The 
reaction was then carried out at 37˚C for 1 hour. The Sigma protocol for glutamine 
assay was replicated and tested. The glutaminase (E-GLUTEC from Megazyme 
located in Ireland) was supplied as a suspension in 2.5M of lithium sulphate at 1250 
U/mL at 25˚C or 3029 U/mL at 37˚C. To mimic the Sigma protocol, 0.4µL (1.212 
U) of the Megazyme glutaminase was used per assay. 0.4µL of glutaminase was 
mixed with 5mM sodium acetate buffer at pH 4.9 (used only for mixing with 
glutaminase before each assay) to make 50mL before used for the assay. Once all 
of the glutamine has been converted into glutamate, an aliquot of 100µL from the 
glutamine assay reaction chamber will then be used for the glutamate assay.  
The next step was to find the concentration limit of glutamine for each assay. 
Several calculations were made in order to find the ideal concentration, and it was 
found that starting with 3mM of glutamine will equate to 0.3mM glutamate and 
0.3mM of NADH as 100µL aliquot is transferred from the glutamine assay into the 
glutamate assay. 0.3mM of NADH is within the detection limit of the 
spectrophotometer.  
Future work on samples with an unknown concentration of glutamine will have 
to be diluted down if it contains more than 6mM of glutamine in order to stay within 
the detection limits of the spectrophotometer. This may have to be done through 
trial and error.  
The next step was to find out the required time needed for the conversion of 
glutamine to glutamate (incubation time). To test this, 100µL of 6mM glutamine, 
50µL of diluted glutaminase (1.212 U), 200µL 0.5M acetate buffer, and 650µL 
deionised water were made and used for the glutamine assay.  
The glutamine samples were then incubated and 16 samples were taken at 16 





Figure 19: Glutamine incubation time test results. 
  
From the graph above, an appropriate incubation period can be determined for 
this assay. The one hour incubation period suggested by Sigma-Aldrich is excessive 
and a shorter period of about 40 minutes should suffice.   
To minimise work and accelerate the whole process, an alternative procedure 
for this assay was tested. This procedure combines both the glutamine and 
glutamate assay together in a single reaction chamber. To test this, both reagents 
needed for the glutamine assay and the glutamate assay were put into one reaction 
chamber. These included NAD+, ADP, glutamine, glutaminase, and buffers (TE 
buffer at pH 9.5 and Acetate buffer 0.5M, pH 5) at concentrations and volumes 
specified earlier. The mixture were then incubated at 37˚C for 40 minutes. Straight 
after the incubation period, GLDH are then added to the mixture and NADH are 
quantified using the spectrophotometer.  
Unfortunately, there were no change in the absorbance value after GLDH was 
added to all of the samples tested. This demonstrates that the two assay cannot be 
done simultaneously. It is speculated that the presence of both buffers may be 






















2.2.1 Optimised glutamine assay  
The final set of conditions were selected based on the results of the tests and 
calculations presented above. 
 
Table 6: Final set of conditions for glutamine assay. The values described below are 
representative for one assay. *Not to be confused with 5mM sodium acetate buffer at 
pH 4.9 used to mix the glutaminase before each assay.  
Sample containing glutamine  100µL at (3mM) 
Acetate buffer* 200µL at 0.5M, pH 5  
Deionised water  650µL 
Glutaminase (0.4µL diluted to 50µL 
with 5mM of sodium acetate buffer at 
pH 4.9) 
50µL at 1.212U 
Incubation at 37˚C for 40 minutes. 
50µL is then used for glutamate assay.  
 
2.2.2 Glutamine assay standard curve  
Using the conditions set out for the glutamine assay, a standard curve was 
generated in order to determine samples with unknown concentration of glutamine. 
Four glutamine concentrations ranging from 0.1mM to 0.4mM were made and 
measured multiple times to get an average reading. The results are presented in 





Figure 20: Glutamine assay standard curve along with equation. 
The formula used to calculate the concentration of glutamine from absorbance is: 
𝒚 = −𝟓. 𝟑𝟓𝒙𝟐 + 𝟓. 𝟑𝟎𝟗𝒙 − 𝟎. 𝟎𝟐𝟗𝟓 
 
2.3 Glutamate and glutamine stability under glutamine 
assay condition  
Out of the two methods presented above, only the glutamine assay requires a 
substantial incubation period. The incubation time was necessary in order to convert 
the glutamine into glutamate, before it is quantified using the glutamate assay. The 
incubation is at 37˚C for 40 minutes. A test was then conducted to ensure the 
glutamate and glutamine does not degrade during the incubation period. To test this, 
glutamine (6mM) and glutamate (0.4mM) were subjected to a 80 minute incubation 
at 37˚C along with all of the reagents required for the glutamine assay (acetate 
buffer, 0.5M at pH 5) with the exception of glutaminase. The results showed that 
even when subjected to twice the incubation period, both glutamine and glutamate 

























2.4 Quantification of pyroglutamic acid 
The HPLC set up was as follows:  
 
Figure 21: HPLC set up. 
 
A Waters 515 HPLC pump running isocratically was used for this assay. The 
flow rate was chosen based on the capacity of the column (BrownleeTM Columns, 
Spheri-5 RP-18, 5µm, 220 X 4.6 mm), which has a maximum pressure limit of 2000 
psi. 0.64mL per minute was found to be the fastest flow rate while keeping the 
pressure below 2000psi. A Hamilton® HPLC syringe 51mm in length with 22s ga 
(blunt tip) needle was used for sample injection. 100µL was chosen as the sample 
volume in order to sufficiently fill the 20µL injection loop. A Waters 2996 
photodiode array detector set to 200nm was used to detect pyroglutamic acid (Shih, 
1985).  
The system functioned well and gave clear results. In this case, the retention 






Figure 22: Chromatogram for pyroglutamic acid only. 
 
2.4.1 Methionine interference  
Previous studies have reported that methionine is also detected at 200nm 
(Gandini, et al., 1993), but the retention time for methionine was unknown for this 
set up. Trials were carried out to examine potential interference from methionine 





































Figure 23: Chromatogram for methionine at 0.5mM dissolved in the mobile phase.  
 
Figure 24: Chromatogram for pyroglutamic acid and methionine combined at 0.5mM 
dissolved in the mobile phase. 
  
Unfortunately, the retention time for methionine under this set up is around 6.4 
minutes (Figure 23). Combining both methionine and pyroglutamic acid together 
showed the peaks overlapping each other (Figure 24), and thus a way of eliminating 







































samples containing both pyroglutamic acid and methionine with 35% m/v H2O2 for 
one hour at room temperature was found to be sufficient in eliminating the presence 
of methionine but preserving the concentration and integrity of pyroglutamic acid 
(Gandini, et al., 1993). The addition of H2O2 (an example of a reactive oxygen 
species) oxidises the SH- group of methionine into methionine sulfoxide (Figure 




Tests were carried out to confirm that H2O2 treatment eliminates methionine 
from detection while preserving pyroglutamic acid. Condition for the tests are 
presented in Table 7. 
Table 7: Methionine elimination test outline (PGA=Pyroglutamic acid and 
MET=Methionine). 
Conditions  1 2 3 4 5 6 
Components PGA Met PGA Met PGA + 
Met 




No No Yes Yes Yes Yes 
 
Conditions 1 and 2 were the controls of this test. The chromatograms from these 
conditions were as expected, with a single peak for both pyroglutamic acid and 
methionine at approximately the same retention time (data not shown). Conditions 
Methionine  Methionine Sulfoxide 
H2O
2 





3 and 4 were the samples that were treated with 30% m/v H2O2 for one hour. The 
chromatogram from condition 3 gave a clear peak (with similar peak height to 
condition 1) at around 6 minutes, and the chromatogram from condition 4 showed 
no peak at the expected retention time for methionine (data not shown). The 
chromatogram from condition 5 also gave a clear single peak at around 6 minutes 
and no other peaks were visible (identical to Condition 3), indicating the absence 
of methionine (data not shown). It is also important to mention that for every 
samples treated with H2O2, there is always a peak at 4 minutes retention time. The 
peak at 4 minutes was found to be a signature peak for H2O2. The chromatogram 
from condition 6 (data not shown) showed a single peak at 4 minutes retention time.  
The conclusion of this test reveals that 30% m/v H2O2 treatment for one hour 
was sufficient in eliminating methionine detection.  
 
2.4.2 Pyroglutamic acid HPLC standard curve  
Using the set up described above, a standard curve was then generated in order 
to determine samples with unknown concentration of pyroglutamic acid. The first 
trial in making a standard curve for pyroglutamic acid used a range of 
concentrations from 0.1mM to 5mM. After examining the peaks from these 
concentrations, it was found that pyroglutamic acid peaks for concentrations above 
0.8mM were shouldering (Figure 26). 
 
Figure 26: Peak shouldering example. Chromatogram of pyroglutamic acid only at a 



















This shouldering will effectively alter the accuracy of the results as the primary 
results are based on the height of the peaks. Another set of lower concentrations 
were then made in an attempt for another standard curve. This time, the standard 
curve was made with concentrations limited to 0.8mM. No shouldering occurred 
and the results are presented in Figure 27. 
 
Figure 27: Pyroglutamic acid standard curve along with equation. 
The formula used to calculate the concentration of glutamine from absorbance is: 



























3  Chapter 3  
HCP337  
3.1 HCP337 production process 
Using the methods described in Chapter 2, a commercial flavour component 
called HCP337 from The Tatua Co-operative Dairy Company was characterised to 
understand the biochemistry of glutamate release during its production. 
HCP337 is a flavour component that is made by digesting casein hydrolysate by 
several different proteases and peptidases. The main goal of the HCP337 production 
process is to digest casein hydrolysate protein and liberate as much free glutamate 
as possible. The free glutamate in the final product can then be used as a flavour 
ingredient and substitute for MSG in the production of flavours at Tatua. The 
HCP337 product is most important in the production of cheese flavour ingredients 
as umami/savouriness is crucial for many of Tatua’s cheese flavour products.  
Currently, the HCP337 production process takes around 83 hours (Table 8). The 
whole process consists of two major hydrolysis stages using three different 
proteases and peptidases. pH adjustments and heat treatments are performed after 
each hydrolysis step in order to deactivate the enzymes and as a control for 
microbial growth. Once the two hydrolysis steps are done, the HCP337 slurry is put 
through a centrifuge and separated by density. The centrifugation process separates 
HCP337 into two forms: “clarification overflow” (supernatant) and “clarification 
discharge” (solid pellet residue). The clarification discharge is discarded, while the 
clarification overflow goes into the final processing steps and becomes the HCP337 
powder/product. During the final steps, the clarification overflow is evaporated 
under vacuum and concentrated. This process leads to the last major step, the spray 
drying of the thick slurry and transforming it into a fine powder.  
The challenge for Tatua is that not much of the glutamate theoretically available 
from casein is actually present in the final product. On average, about 20-25g/kg of 
glutamate is present in the final HCP337 powder (recognising that inter-batch 
variations exist), whereas in theory a complete hydrolysis of casein releasing all of 










Samples taken for testing  
Half of the casein added 0 1.7 55 After tipping of casein was completed 
Enzyme 1 added (Start of first hydrolysis) 6.2 2.4 55  8 hours into the first hydrolysis 
 16 hours into the first hydrolysis 
 24 hours into the first hydrolysis, before the pH adjustment 
Tipping start second half casein 6.33 2.8 54 
Tipping finished 7.2 3.8 54 
Enzyme 2 add (total hydrolysis 24h from 1st 
enzyme) 
7.33 3.8 53 
Heat treatment for 93 seconds  31.2 5.2 125 After the first heat treatment 
Enzyme 3 add (start of second hydrolysis) 
(total hydrolysis 34h) 
35.3 5.12 53  12 hours into the second hydrolysis 
 24 hours into the second hydrolysis 
 34 hours into the second hydrolysis, before the pH adjustment 
Heat treatment for 77 seconds  80.4 6.7 125 A sample was taken after the second heat treatment. 
Clarifier 80.5 6.7 55 Two samples: clarification solids and overflow 
Evaporation 82.7 6.7 65  





Table 9: Average concentrations of glutamate and glutamine from the HCP337 production process samples (December 2015 batch), and the corresponding 
standard deviation. Important to note that the glutamine values represent glutamine and endogenous glutamate.   
 Glutamate  Glutamine + Glutamate 










Casein - - - - 
Tipping complete 0.000 0.000 0.000 0.000 
1st hydrolysis 8hr 1.117 0.008 5.602 0.262 
1st hydrolysis 16hr 3.885 0.107 9.420 0.271 
1st hydrolysis finish, before pH adjustment 5.686 0.472 12.212 0.780 
After 1st heat treatment 6.419 1.136 10.694 0.928 
2nd hydrolysis 12hr 15.896 0.228 19.347 0.374 
2nd hydrolysis 24hr 18.737 0.408 26.917 0.988 
2nd hydrolysis finishes before pH adjustment 20.509 1.097 25.349 1.039 
After 2nd deactivation 18.069 0.721 23.940 0.862 
Clarifier solids 12.453 0.954 19.437 0.600 
Overflow 17.169 0.089 22.104 0.888 








Table 10: Quantitative results of the HCP337 production process from December 2015 batch. Concentration in g/kg (according to the total solid % of each 
sample). Glu=Glutamate, Gln= Glutamine, and PGA= Pyroglutamic acid. 
Time Sample Total Solids (%) Glu (g/kg) Gln (g/kg) PGA (g/kg) 
 Acid Casein  13.4  0  0   
7:15 Tipping complete 13.4  0  0   
13:20 1st hydrolysis 8hr 13.4 1.2 4.9   
21:20 1st hydrolysis 16hr  13.4 4.3 6.1   
5:20 1st hydrolysis finish, before pH adjustment 13.4 6.2 7.1   
11:05 After 1st heat treatment 13.4 7.0 4.7   
0:00 2nd hydrolysis 12hr 13.4 17.5 3.8   
11:20 2nd hydrolysis 24hr 13.4 20.6 9.0   
21:20 2nd hydrolysis finishes before pH adjustment 13.4 22.5 5.3   
2:20 After 2nd deactivation  13.4 19.8 6.4   
2:30 Clarifier solids 17.0 10.8 6.1   
2:30 Overflow 14.4 17.5 5.1 24.9 




3.2 HCP337 (December 2015)  
Quantitative analysis was done for samples taken from the HCP337 production 
process. Glutamate and glutamine assays were done in triplicates, while 
pyroglutamic acid quantifications were only done in duplicates. Even though the 
retention time for pyroglutamic acid is around 6 minutes, the total time for the 
system to expel the sample was around 40 minutes (before another sample can be 
injected and tested). The results are presented in Tables 9 and 10:    
Unlike glutamate and glutamine, pyroglutamic acid was only quantified in the 
final two samples of the HCP337 production process. The final two samples 
contained high enough pyroglutamic acid for a peak to be visible at 6 minutes 
retention time. Other samples prior to this step did not show a clear peak as it was 
hidden beneath the noise due to the complexity of the samples tested.  
At the beginning of the process, casein was found to have no free glutamate or 
glutamine. The first hydrolysis yielded 6.2g/kg of glutamate and 7.1g/kg of 
glutamine over 24 hours. The first heat treatment was done at 125˚C with no 
apparent negative effect on glutamate concentration. In fact, the concentration of 
glutamate seemed to increase from 6.2 to 7.0g/kg after the first heat treatment. The 
increase of glutamate may be due to the residual activity of the enzyme that 
managed to survive the heat treatment. The same observation however cannot be 
said for glutamine. The first heat treatment appeared to have decreased the 
concentration of glutamine from 7.1 to 4.7g/kg. This drop suggest that glutamine is 
unstable under the heat treatment conditions, which is consistent with previous 
studies done on glutamine stability (Section 1.5).  
After the first heat treatment, the second hydrolysis starts with the addition of 
the third protease. The second hydrolysis is different to the first one in several 
aspects: only one protease is involved in this hydrolysis, the total hydrolysis time is 
34 hours, and the pH for the second hydrolysis was kept constant at 5.1.  
12 hours into the second hydrolysis, the concentration of glutamate increased 
very rapidly. At this point, the samples gave an average reading of 17.5g/kg of 
glutamate. In contrast, the concentration of glutamine has dropped even more from 
the previous sample point. In theory, the concentration of glutamine should have 
increased as the protease break down the casein peptides even more. However, this 




than the rate of glutamine release by the second hydrolysis. At the 24 hour mark 
into the second hydrolysis, glutamate concentration had increased even more, 
however the rate of increase is significantly lower compared to the first 12 hours. 
The decelerating rate of glutamate release is evident for the rest of the hydrolysis 
period, where the concentration of glutamate had only increased by a small amount 
at the 34 hour mark compared to the 24 hour mark. On the other hand, there was a 
substantial increase of glutamine from the 12 hour mark to the 24 hour mark but 
this was then followed by a significant drop in glutamine concentration from the 24 
hour mark to the 34 hour mark. Unlike the first deactivation process, the second 
deactivation process affected the concentration of glutamate negatively, evident by 
the drop in glutamate concentration from 22.5g/kg to 19.8g/kg after the second 
deactivation process.  
As mentioned above, at this point the slurry is separated in a centrifuge into 
clarifier solids and overflow. The results showed that the clarifier solids, which 
comprise most of the undissolved particulates, contain a large amount of glutamate 
and a smaller amount of glutamine. This suggests that the precipitate in the clarifier 
solids sample contains a lot of trapped glutamate that is discarded.   
The overflow sample in this case has a glutamate concentration of 17.5g/kg, 
glutamine content of 5.1g/kg, and remarkably a very high concentration of 
pyroglutamic acid of 24.9g/kg.  
At the end, the HCP337 powder contains 21.1g/kg of glutamate, 5.0g/kg of 
glutamine, and 32.4g/kg of pyroglutamic acid. To verify the accuracy of the data 
presented here, an independent quantification of glutamate by AgResearch was 
carried out. The method of quantification done by AgResearch employed a free 
amino acid analysis which is based on precipitation of peptides with 2% 
sulphosalicylic acid followed by ion exchange chromatography with a lithium 
buffer system. AgResearch found that the HCP337 powder from the same batch 
used for this study has a glutamate concentration of 23.2g/kg. This value is very 
close to the 21.1 g/kg of glutamate presented from this study.  
3.3 HCP337 (March 2016) 
The results presented so far on the HCP337 production process were done using 
samples from a single batch. To gain further understanding on this process and the 




the infrequent nature of HCP337 production, only two batches were analysed 
during the course of this study.  
The second batch of HCP337 was produced in March, 2016. Unfortunately, 
when the decision to analyse the samples was made, the production for HCP337 
was already in process, and thus samples were only obtained from the clarification 




Table 11: Average concentrations of glutamate and glutamine from the HCP337 production process samples (March 2016 batch), and the corresponding 
standard deviation. Important to note that the glutamine values represent glutamine and endogenous glutamate.   













Clarification Feed Flow Start 22.756 0.100 2.467 0.799 
Middle 24.605 0.507 34.170 0.165 
End 23.910 0.660 33.045 0.325 
Clarification Overflow Start 15.509 0.196 27.787 0.945 
Middle 16.936 0.286 33.480 0.821 
End 17.257 0.110 34.243 0.218 
Clarification Discharge  Start 17.892 0.814 27.467 0.108 
Middle 19.418 0.241 28.528 0.487 
End 18.628 0.223 26.940 1.141 
Evaporator Sample  Start 57.261 0.670 82.102 0.423 
Middle 57.542 0.629 87.250 0.807 
End 59.555 0.336 87.978 0.812 
Concentration tank 
Sample  
Start 49.699 0.386 70.408 0.603 
Middle 58.538 0.125 86.815 0.725 
End 58.610 0.072 91.817 0.748 
HCP337c Filtered  48.475 0.628 86.815 0.523 




Table 12: Quantitative results of the HCP337 production process from March 2016 batch. Concentration in g/kg (according to the total solid % of each 
sample). Glu= Glutamate, Gln= Glutamine, and PGA= Pyroglutamic acid. 
Sample Sampling Period  Total Solids (%) Glu (g/kg) Gln (g/kg) PGA (g/kg) 
Clarification Feed Flow Start        
Middle        
End        
Clarification Overflow Start 14.4 15.8 12.6 17.4 
Middle 14.4 17.3 16.9   
End 14.4 17.6 17.4   
Clarification Discharge  Start 17.0 15.5  8.3   
Middle 17.0 16.8  7.9   
End 17.0 16.1 7.2    
Evaporator Sample  Start        
Middle        
End        
Concentration tank Sample  Start        
Middle        
End        
HCP337c Filtered         




The concentrations of glutamate from the overflow samples of the two batches 
were similar (Table 13). However the concentration of glutamine in the new 
overflow sample was a lot higher compared to the previous batch. On top of these, 
the pyroglutamic acid concentration in the new overflow samples were lower 
relative to the previous batch. At this stage, it was assumed that when glutamine is 
lost, it is converted to pyroglutamic acid. If this assumption is true, then the low 
concentration of glutamine in overflow sample from the old batch would be due to 
its spontaneous conversion into pyroglutamic acid.  
Similarly, the clarification discharge samples from the new batch (the same as 
clarified solids samples from the previous batch) also contained a high 
concentration of glutamate and a lower concentration of glutamine relative to 
glutamate. This once again shows that the discarded clarification discharge products 
contain a lot of glutamate and to a lesser extent glutamine. 
Lastly, the HCP337 powder from the new batch contains a slightly higher 
concentration of glutamate, slightly lower concentration of glutamine, and slightly 
higher concentration of pyroglutamic acid when compared to the old batch (Table 
13). Unlike the old batch, data for the new batch suggest that more than half of the 
pyroglutamic acid present in the final powder is formed during the drying process 
at the end. The high temperature of 200˚C in the spray drying process is the likely 
culprit for the formation of pyroglutamic acid (Gayte-Sorbier, et al., 1985; Arii, et 
al., 1999).  
 
Table 13: Glutamate, glutamine, and pyroglutamic acid concentration comparison 
between the two HCP337 batches. *values depicted are the average value of the three 
sampling periods. 


























10.8 16.1* 6.1 7.8*   
Overflow  17.5 16.9* 5.1 15.6* 24.9 17.4 
HCP337 
Powder 




3.4 Clarification solids 
The tests done on the HCP337 samples reveal that clarified solids discarded 
from the HCP337 production process have a relatively high glutamate content. To 
better understand how much glutamate is wasted from discarding the clarifier 
solids, a mass balance analysis of the HCP337 production process was carried out. 
The information presented below represents the last few steps within the HCP337 










From the calculations above, it is clear that the amount of glutamate wasted 
from discarding the clarifier solids is significant.  
 
3.4.1 The big picture 
The purpose of this section is to analyse and gain perspective on the glutamate 
present in the HCP337 product, the glutamate loss in the clarification process, and 
the potential glutamate still available in casein. The HCP337 production process for 
both the December 2015 and March 2016 batch started with x kg of lactic casein as 
the substrate. Theoretically, casein contains 134.5g/kg of glutamate (Yildiz, 2010). 
Thus, in theory, the potential glutamate that is present in the casein used to make 
HCP337 is y kg (this is 100% of the potential glutamate present in casein). Below 
is a graph representing the percentage of glutamate utilised in the HCP337 
production process.  
 
 
Figure 29: Perspective view (from both batches) on the glutamate present in the 
HCP337 products (free glutamate), the glutamate loss in the clarification process, and 














December 2015 batch 84.7 2.6 12.7



















It is fair to say that relative to the glutamate present in the final HCP337 powder, 
the amount of glutamate lost from discarding the clarified solids is significant. 
Furthermore, the amount of bound glutamate still present in the casein polypeptides 
is enormous relative to the amount of free glutamate in the HCP337 product. 
Presumably most of the undigested casein polypeptides are discarded in the 
clarified solids. These findings are true for the two batches tested in this study.  
3.5 Glutamate and glutamine stability test 
The results confirmed sub-optimal glutamate released by the HCP337 
production process. The results also confirmed the presence of pyroglutamic acid 
in the final HCP337 product in significant amounts. The next step was to find the 
origin of pyroglutamic acid. Both glutamate and glutamine were tested by 
subjecting them to the two hydrolysis conditions. The buffer chosen for this test 
was acetate buffer at 0.2M. Both glutamate and glutamine were dissolved with the 
acetate buffer (at differing pH) at a concentration of 0.3mM. The dissolved 
glutamate and glutamine were then transferred into 1.5mL Micro tube, and were 
sealed with Parafilm in order to prevent any moisture loss due to evaporation of 
water during the test. The individual Micro tube were then put into an Eppendorf 
Thermomixer which was set to 53˚C and constantly mix at 800 RPM. For 
‘Condition 1’ samples were taken at 0, 3, 6, and 24 hour time intervals. For 
‘Condition 2’, samples were taken at 6, 24, and 34 hour intervals. The results of the 
tests are presented in Table 14.  
 
Table 14: Raw results of glutamine concentrations from all of the sample points in 
condition 1 (conditions of the first hydrolysis) and 2 (conditions of the second 
hydrolysis).  
Condition 1  Condition 2 
Hours Concentration 
(mM) 
% Hours Concentration 
(mM) 
% 
0 0.313 100 0 0.328 100 
3 0.302 96.4 9 0.310 94.5 
9 0.261 83.3 24 0.259 78.9 




Figure 30: Side by side comparison of glutamine and glutamate degradation from 
condition 1 and condition 2. 
 
Clearly, glutamate is very stable when subjected to both hydrolysis conditions 
(Figure 30). No degradation was observed under either condition.   
The results here agree with a previous report of glutamate’s stability under 
various conditions (Gayte-Sorbier, et al., 1985).  
 
3.5.1 Glutamine stability  
In contrast, glutamine was found to be much less stable (Figure 30). In the first 
hydrolysis condition glutamine dropped to 57% of its original concentration in 24 
hours (from 0.313mM to 0.177mM). In the second hydrolysis condition, where the 
pH was slightly higher, glutamine was found to be more stable as it only degraded 
to 79% of its original concentration after 24 hours (from 0.328mM to 0.259mM). 
After 34 hours, the glutamine dropped even further to 70% of its original 
concentration (to 0.229mM). The rate of glutamine degradation from both 
conditions showed linear decrease over time. The degradation of glutamine 












0 5 10 15 20 25 30 35 40
%
Time (Hours)
Side by side comparison of glutamine and glutamate 
degradation in both conditions
Glutamine (Condition 1) Glutamine (Condition 2)
Glutamate (Condition 1) Glutamate (Condition 2)
 
54 
both conditions showed an R2 of over 0.99 (data not shown). The rate of glutamine 
degradation is much faster at pH 4 compared to pH 5.1.  
The results for glutamine degradation were also supported by a previous study 
done in 1999 by Arii et al which found that at 70˚C and pH 3.93, the rate of 
glutamine degradation is much faster than that at pH 4.80 (Arii, et al., 1999). It 
takes about 8 hours before the glutamine concentration reach half of its original 
value at pH 3.93 (Arii, et al., 1999). On the other hand it takes about 17 hours before 
the glutamine concentration reach half of its original value at pH 4.80 (Arii, et al., 
1999). These results were in line with the results from this stability test. 
Extrapolating the data from Figure 30 suggests that in condition 1, it takes 27.5 
hours before the glutamine reach half of its original value. On the other hand it takes 
about 55.9 hours before the glutamine concentration reach half of its original value 
in condition 2. The longer times required to reach half of the glutamine’s original 
value is due to the lower temperature used for this test.  
 
3.6  Origin of pyroglutamic acid  
The question at this stage was: Does spontaneous conversion to pyroglutamic 
acid explain all of the glutamine losses? 
To answer this question, HPLC tests were performed for the end samples (24 
hours and 34 hours) of the stability tests in order to see if there is any pyroglutamic 
acid present. First, glutamine samples at time zero were tested to find the retention 




Figure 31: Chromatogram of the untreated glutamine sample, 0.64ml/min. 
 
In Figure 31, there is a clear peak at 4.29 minutes which corresponds to 
glutamine, and analysis of additional samples showed a similar profile. The 
chromatogram however also showed a very small peak at 5.86 minutes which 
corresponds to pyroglutamic acid. In a perfect world, these samples of untreated 
glutamine should have no pyroglutamic acid peak at all, however all of the samples 
in this test were subjected to freezing before it was tested. The freezing and thawing 
effect may be responsible for the minute formation of pyroglutamic acid from 

















































































































































































































Figure 32: Chromatogram of the end product of ‘condition 2’, at 200nm, 0.64ml/min. 
 
Figure 32 portrays a chromatogram of the end product of the glutamine sample 
at pH 5.1 (condition 2). The chromatogram showed two distinct peaks at 4.31 
minutes that corresponds to glutamine at 200nm and one at 5.87 minutes. The 
pyroglutamic acid peak appeared uninterrupted by the glutamine peak. The results 
from both conditions were then collected and presented as below. 
 
Table 15: Pyroglutamic acid results converted from peak height to concentration. 






























Since the stoichiometry of glutamine to pyroglutamic acid conversion is 1 to 1, 






























































































1.00 2.00 3.00 4.00 5.00 6.00 7.00
 
57 
the degradation of glutamine solely by subtracting the initial glutamine 
concentration by the final glutamine concentration at the end of the tests. 
Under condition 1, the decrease in glutamine concentration is 0.136mM after 24 
hours. This observation consistent with the detected pyroglutamic acid 
concentration of 0.136mM. In condition 2, the difference in glutamine 
concentration is 0.099mM after 34 hours. This conjecture was proven to be correct 
when the end sample of condition 1 was tested in the HPLC and revealing a 
pyroglutamic acid concentration of 0.100mM.  
These results confirms that all of the glutamine loss from the hydrolysis 
conditions were spontaneously converted to pyroglutamic acid.  
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4 Chapter 4 
Maximising glutamate release 
4.1 Introduction  
Quantitative analyses of glutamate, glutamine, and pyroglutamic acid of the 
HCP337 production process revealed that indeed there was sub-optimal glutamate 
levels in the end product relative to the theoretical glutamate concentration found 
in casein. Knowing that glutamate is stable under the conditions within the HCP337 
production process, the next step was to find ways in increasing glutamate release 
from casein. 
On the other hand, speculation of the presence of pyroglutamic acid was proven. 
Pyroglutamic acid was present in substantial amount in the end products, and 
further testing showed that glutamine is responsible for the formation of 
pyroglutamic acid during the production of HCP337 due to its instability. Knowing 
this, a logical step was to find a way to convert the glutamine released to glutamate 
before it converts into pyroglutamic acid spontaneously.  
The names of the enzyme tested in this chapter (including enzymes used in the 
HCP337 production process) are withheld as they are proprietary information.  
 
4.2 Effects of phosphoric acid and hydrochloric acid on 
enzyme activity 
The current HCP337 production process uses phosphoric acid in the initial step 
of the process to decrease the pH. Does the use of phosphoric acid have any negative 
effects towards the enzyme used for proteolysis? To answer this, two of the three 
enzymes currently used in the HCP337 production process (Enzyme A and Enzyme 
B) were tested at pH 3-7 and 53˚C for 4 hours. The substrate used for this test is the 
HCP337 powder, which evidently still contains a lot of bound glutamate (see 
Chapter 3). No buffer was used in this test as the HCP337 powder has buffering 
capacity of its own. Acidification were done using phosphoric acid and 
hydrochloric acid for comparison. For phosphoric acid, samples were first acidified 
to pH 3.8, then titrated back to the desired pH using sodium hydroxide or more 
phosphoric acid in the case of pH 3. This is done to ensure that every samples have 
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phosphoric acid present despite the different pH. In contrast, samples that were 
acidified with hydrochloric acid did not undergo the initial acidification to pH 3.8; 
rather, hydrochloric acid was used to adjust the samples straight to the desired pH. 
The substrate concentration for this test was 10% of the total volume, and the 
enzyme concentrations was 0.1%. The results are presented in Figures 33 and 34. 
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Figure 34: Glutamine loss for both enzymes under the two different conditions.  
 
Table 16: Difference in proteolytic activity of both enzymes in or without the presence 
of phosphoric acid in terms of P-value. 
Enzyme A  
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To support the results obtained in this test, paired t-tests were performed using 
Microsoft Excel 2013, and the P-values (Table 16) were compared. The P-values 
were interpreted in terms of a significance level (α) of 0.05.  
The data presented in Figure 33 is the mean difference in glutamate yield after 
four hours of digesting HCP337 powder. To obtain the difference standard 
deviation (𝜎𝑓) between time zero and time four hours, this formula was used:  
𝜎𝑓 = √𝜎𝐴
2 + 𝜎𝐵
2 − 2𝑐𝑜𝑣𝐴𝐵 
Where 𝜎𝐴
2 is the square of the standard deviation at time 0, 𝜎𝐵
2 is the square of 
the standard deviation at time 4, and 𝑐𝑜𝑣 is the covariance from time 0 and time 4.  
 
4.2.2 Discussion  
The null hypothesis is that phosphoric acid does not alter the ability of the 
enzymes to release glutamate from casein, and thus no difference in enzyme activity 
is seen. Overall, the experimental data reject the null hypothesis. 
Enzyme B appears more efficient at releasing glutamate in the absence of 
phosphoric acid. The activity level at all pH values are better and in some cases 
significantly better in the absence of phosphoric acid (Figure 33). Furthermore, the 
pH optima of Enzyme B shifts from pH 4 in the presence of phosphoric acid, to pH 
5 in the absence of phosphoric acid (Figure 33). On the other hand, Enzyme A 
activity was better in the presence of phosphoric acid, in most pH, except for pH 7 
(Figure 33).  
The control for this test used water instead of an enzyme and the results showed 
that there was very little spontaneous release of glutamate due to the processing 
conditions in the absence of any enzyme (Figure 33).    
Lastly, glutamine in all of the samples for this test were also assayed and the 
results clearly shows that no further glutamine were gained. In fact, the amount of 
glutamine decreases from time zero to time four hours for every samples tested. 
The decrease in glutamine observed is most likely due to the instability of glutamine 
under the test condition.  
Using hydrochloric acid instead of phosphoric acid may be the better option in 
terms of increasing glutamate yield for Enzyme B. However it was then pointed out 
that hydrochloric acid may have a negative impact over time on the apparatus used 
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to make the flavours at Tatua, which are mostly made out of stainless steel. In 
general, acids used on stainless steel should always have both reducing and 
oxidising properties in order to maintain the ‘passive’ corrosion resistant surface 
layer (British Stainless Steel Association, n.d.).  Hydrochloric acid unfortunately 
lacks the ability to oxidise thus, prolong contact of stainless steel with hydrochloric 
acid can eventually cause pitting corrosion (British Stainless Steel Association, 
n.d.). Therefore, is the gain in glutamate yield by using hydrochloric acid worth the 
consequences of stainless steel pitting corrosion over time?  
 
4.3 New enzyme peptidase activity test  
Using the same set up and methodology from Section 4.2, proteolytic capacity 
of four new enzymes were tested. These enzymes are labelled as Enzyme C through 
Enzyme F. In this case, only phosphoric acid is used for acidification. The results 
were as follows:  
 
Figure 35: Proteolytic activity comparison between the new enzymes. Glutamate yield 
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4.3.1 Discussion  
In general, all of the new enzymes tested show a tendency to be most efficient 
at releasing glutamate at neutral pH (Figure 35). This was expected as most of these 
enzymes are glutaminase-containing enzyme preparation that are most active at 
near neutral pH (Dura, et al., 2002). Thus the efficacy of these enzymes at neutral 
pH is most likely due to the presence of glutaminase.  
Enzyme C was seen to be the best enzyme in terms of glutamate yield after 4 
hours at pH 7 (Figure 35). The second best enzyme was found to be Enzyme E, 
once again at pH 7 (Figure 35). Both Enzyme D and Enzyme F were very close 
together in terms of glutamate yield in the higher pH values. However, Enzyme D 
and Enzyme F was inferior when compared to the glutamate yield of Enzyme C and 
Enzyme E in the higher pH values (Figure 35). One major difference between these 
new enzymes and the current enzymes used in the making of HCP337 product is 
that these new enzymes have the tendency to be most active (operate optimally) in 
the neutral pH, as oppose to the more acidic pH of the enzymes currently used.  
 The standard deviations (error bars) for the mean concentration of glutamate 
from the 4 hour hydrolysis (Figure 35) were calculated using the formula stated in 
Section 4.2.1.  
Glutamine was also assayed for each samples of this test, however the assays 
revealed very minimal glutamine presence, and the data were not included. 
Since the conditions of this test is the same as the conditions done to test the 
two current enzymes (Section 4.2), the results from this test are thus comparable. 
Combining all of the results gives a better understanding and perspective on the 





Figure 36: Proteolytic comparison between all of the enzymes (currently used 
[Enzyme A and B in phosphoric acid] and new), without error bars. Glutamate yield 
are measured in g/kg. 
 
From the two tests, it is clear that Enzyme A was the most active at releasing 
glutamate over the 4 hour test period (Figure 36). Enzyme C was another enzyme 
with significant glutamate yield at pH 7 (Figure 36). Enzyme B has a similar 
maximum glutamate yield with Enzyme E (Figure 36), the only difference is the 
pH optima.  
Lastly, the proportion of glutamate yield by the 4 hour tests (specifically by 
Enzyme A) was found to be a lot when compared to the average glutamate yield 
from the entire HCP337 production process which in total takes 58 hours of 
digestion time. What is the reason behind this anomaly? One speculation that can 
be made is that perhaps the enzyme are being denatured over the long period of 
HCP337 processing. Looking at the enzyme manufacture’s guideline revealed that 
80% of Enzyme A inactivation occurs at 50˚C for an unspecified time interval. On 
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HCP337 powder as the substrate, whereas the 58 hours of total digestion time from 
the actual HCP337 production process started from casein.  
4.4 Glutaminase screening  
At the time of this experiment, the use of pure glutaminase in the production of 
flavours at Tatua was not permitted by the Ministry for Primary Industries. The use 
of glutaminase can be of great value as it would help convert the unstable glutamine 
into glutamate before it is converted into pyroglutamic acid spontaneously. Even 
though pure glutaminase was not allowed, there are several enzyme preparations 
that are permitted and contain glutaminase as contamination or as a deliberate 
component of the enzyme preparation. Four enzymes (known to have glutaminase 
side activity) were then chosen and tested for their glutaminase activity along with 
the two current enzymes. 
New enzymes (not currently used in the HCP337 production process) that may 
contain glutaminase activity: 
 Enzyme C  
 Enzyme D  
 Enzyme E  
 Enzyme F  
Current enzymes:  
 Enzyme A  
 Enzyme B  
Positive control  
 Known glutaminase 
Negative control 
 Water  
The enzymes were tested at five different pH values ranging from pH 3 to 7. 
The substrate for this test was glutamine and the buffer used were sodium citrate 
buffer for pH 3 to 6, and phosphate buffer for pH 6 to 7 (Table 17). Finding a single 
buffer that could span the pH range for this test would be perfect, unfortunately 
there was no buffer that could span from pH 3 to 7. The solution was to use two 




Table 17: Outline of the buffers used for each pH values. 
pH  3 4 5 6 7 












The test was done at 53˚C for 3 hours. Samples were collected at three time 
intervals (30 minutes, 90 minutes and 180 minutes) in case glutamine is fully 
converted into glutamate before 180 minutes. Glutamine concentration was 6mM, 
and the enzyme concentration was 0.05% in a reaction volume of 2mL. The samples 
were then assayed for glutamate and the results were as follows: 
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4.4.1 Discussion  
Firstly, the negative control of this test showed that there were no spontaneous 
conversion of glutamine into glutamate in the absence of an enzyme (Figure 37), 
and the positive control was found to be active at pH 5 and above (Figure 37).  
Enzyme A and Enzyme B both have very little or no glutaminase activity 
(Figure 37).  
In contrast, the four new enzymes have relatively high glutaminase activity with 
the exception of Enzyme F. The activity of glutaminase from Enzyme C, Enzyme 
D and Enzyme E were very similar in terms of the amount of glutamine converted 
into glutamate (Figure 37). The glutaminase activity in these enzyme preparation 
showed a pH optima of near neutral to neutral (Figure 37). The activity of 
glutaminase in Enzyme F was still relatively high (Figure 37) when compared to 
the two current enzymes, however relatively low when compared to the other three 
new enzymes. Although not very defined, glutaminase in Enzyme F also show a 
tendency to be most active at neutral pH.  
In terms of the different buffers used, the null hypothesis was that the different 
buffers will not cause different proteolytic activity. To test the effects of different 
buffers on the enzyme proteolytic activity, paired t-tests were done (Section 4.2.1) 
and the P-values are presented below.  
Table 18: Difference in proteolytic activity of all enzymes between the two different 
buffers used at pH 6 in terms of P-value.  
Enzyme  P-value 
Enzyme A 0.175 
Enzyme B 0.002 
Enzyme C 0.0116 
Enzyme D 0.766 
Enzyme E 0.002 
Enzyme F 0.003 
Known glutaminase (+ve control) 0.006 
 
Most of the enzymes (Enzyme C, Enzyme E, Enzyme F, Enzyme B, and the 
positive control) was less efficient at converting glutamine to glutamate in the 
presence of phosphate. This is evident from a minute decrease in glutamate 
concentration in phosphate buffer compared to sodium citrate buffer at pH 6 for 
these enzymes (P-values <0.05, Table 18). These observations were further 
supported by the P-values which were below 0.05. In contrast, the enzymes 
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(Enzyme D and Enzyme A) had very little difference in terms of proteolytic activity 
between the two buffer systems. This claim was supported by P-values which were 
above 0.05. As an overall, the experimental data reject the null hypothesis.
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5 Chapter 5 
Conclusion 
 
The main objective of this research was to comprehensively examine the 
biochemistry of glutamate release from casein, finding the optimum proteolysis 
condition and using this knowledge to optimise the current process, increasing 
glutamate release.  
In order to understand the biochemistry of glutamate release from casein, three 
techniques were first developed for this research. The quantification of glutamate, 
glutamine, and pyroglutamic acid were developed and were used extensively 
throughout this project to view and understand why so little glutamate is released 
from casein even with the extensive digestion time of the HCP337 production 
process.  
Applying these techniques and testing the samples from the HCP337 production 
process revealed that there was very little glutamate yield in the HCP337 product 
relative to the theoretical concentration of glutamate in casein even after 83 hours 
of production time and two digestion processes. On top of this, the amount of 
glutamate wasted as the clarified solids was high relative to the amount of glutamate 
present in the HCP337 product. Additionally, the concentration of pyroglutamic 
acid in the HCP337 product was found to be very high. Stability tests on both 
glutamate and glutamine under production conditions revealed that glutamate is 
stable and did not show any sign of reduction in the processing conditions. In 
contrast, glutamine showed a linear decline over time when exposed to the 
production conditions. Glutamine was found to be more unstable when exposed to 
lower pH. Furthermore, testing the end products of the stability test proved that all 
of the glutamine lost was converted into pyroglutamic acid.  
The next step in the project was to find a way to increase glutamate release and 
decrease pyroglutamic acid formation. Initially, it was speculated that the use of 
phosphoric acid in the production of HCP337 was causing a negative impact on the 
enzyme’s ability to liberate glutamate. A test was done to compare the effects of 
two acidifying agents (phosphoric acid and hydrochloric acid) on the enzymes 
currently used in the HCP337 production process. The results showed that there 
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was a slight increase in glutamate yield for one of the two enzymes only. Moreover, 
the use of hydrochloric acid can have negative consequences over time to the 
stainless steel equipment.   
Due to the prohibition of pure glutaminase use in the production of flavours at 
Tatua during the time of this research, a search into finding new enzyme 
preparations containing glutaminase activity was conducted. The presence of 
glutaminase can aid in the increase of glutamate yield in the HCP337 production 
process.  
After testing several new enzyme preparations with possible glutaminase 
activity, one enzyme was found with a promising outcome (Enzyme C). However, 
this enzyme was still inferior in terms of its ability to yield glutamate when 
compared to one of the current enzyme used in the HCP337 production process 
(Enzyme A). Furthermore, it was found that all of the enzyme preparations with 
glutaminase activity showed a neutral pH optima. This was expected as the enzyme 
glutaminase is known to have a pH optima of near neutral.  
These results causes a slight dilemma as the enzymes currently utilised in the 
HCP337 production process has lower pH optima. This means, even if glutaminase 
is allowed to be used, it cannot be combined with the current process as it will not 
be very active at the lower pH. In the likely event of glutaminase being approved 
to be used, more enzymes with near neutral pH optima (like the ones tested in 
Section 4.3) should be screened. Proteases and peptidases most active in neutral pH 
can be combined with glutaminase, thus further increasing the glutamate yield.  
In summary, this project demonstrated that the current HCP337 production 
process does not optimally release glutamate from casein. Changing pH during 
hydrolysis and using alternative enzymes did not appear to effective strategies for 
increasing glutamate release, but the combination of test performed during this 
project is far from exhaustive. The use of glutaminase during the production process 
to convert glutamine into glutamate before it spontaneously converts into 
pyroglutamic acid is potentially an effective strategy for increasing glutamate yield, 
but the current production process will need to be modified to accommodate 
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